期刊
JOURNAL OF ORTHOPAEDIC RESEARCH
卷 29, 期 12, 页码 1812-1819出版社
WILEY-BLACKWELL
DOI: 10.1002/jor.21454
关键词
bone graft substitute; bone morphogenetic protein; spine fusion; nanomatrix; rat model
类别
资金
- Pioneer Surgical, Inc.
- Northwestern University Feinberg School of Medicine, Department of Orthopaedic Surgery
- Medtronic, Inc.
- Baxter
The use of recombinant human bone morphogenetic protein-2 (rhBMP-2) in spine fusion has led to concerns regarding a potential accompanying inflammatory response. This study evaluates a combination therapy (TrioMatrix (R); Pioneer Surgical, Inc., Marquette, MI) comprised of a demineralized bone matrix (DBM), hydroxyapatite, and a nanofiber-based collagen scaffold in a rodent spine fusion model. Thirty-six athymic rats that underwent a posterolateral intertransverse spinal fusion were randomly assigned to 1 of 5 treatment groups: absorbable collagen sponge alone (ACS, negative control), 10 mu g rhBMP-2 on ACS (positive control), TrioMatrix (R), Grafton (R) (Osteotech, Inc., Eatontown, NJ), and DBX (R) (Synthes, Inc., West Chester, PA). Both TrioMatrix (R) and rhBMP-2-treated animals demonstrated 100% fusion rates as graded by manual palpation scores 8 weeks after implantation. This rate was significantly greater than those of the ACS, Grafton (R), and DBX (R) groups. Notably, the use of TrioMatrix (R) as evaluated by microCT quantification led to a greater fusion mass volume when compared to all other groups, including the rhBMP-2 group. T2-weighted axial MRI images of the fusion bed demonstrated a significant host response associated with a large fluid collection with the use of rhBMP-2; this response was significantly reduced with the use of TrioMatrix (R). Our results therefore demonstrate that a nanocomposite therapy represents a promising, cost-effective bone graft substitute that could be useful in spine fusions where BMP-2 is contraindicated. (C) 2011 Orthopaedic Research Society. Published by Wiley Periodicals, Inc. J Orthop Res 29: 1812-1819, 2011
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据